SC
EW icon

Syon Capital’s Edwards Lifesciences EW Stock Holding History

Syon Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Buy
11,935
+3,844
+48% +$322K 0.05% 324
2026
Q1 		$648K Buy
8,091
+791
+11% +$65.2K 0.03% 462
2025
Q4 		$622K Buy
7,300
+541
+8% +$44.4K 0.03% 479
2025
Q3 		$526K Buy
6,759
+861
+15% +$67.3K 0.03% 478
2025
Q2 		$461K Buy
5,898
+1,227
+26% +$91.5K 0.03% 401
2025
Q1 		$339K Sell
4,671
-136
-3% -$9.73K 0.03% 389
2024
Q4 		$356K Buy
+4,807
New +$336K 0.03% 362
2024
Q3 		– Sell
-3,748
Closed -$346K – 473
2024
Q2 		$346K Sell
3,748
-131
-3% -$11.6K 0.03% 323
2024
Q1 		$371K Buy
+3,879
New +$326K 0.04% 317

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Syon Capital's EW Position: Q2 2026 in Review

Syon Capital increased its Edwards Lifesciences (EW) stake by 48% in Q2 2026, buying an estimated $322K and bringing the position to 11,935 shares worth $1.08M. The position accounts for 0.05% of the portfolio, ranked #324.

Syon Capital first reported a position in EW in Q1 2024 and has held it in 9 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Syon Capital held 11,935 shares of Edwards Lifesciences worth $1.08M as of Q2 2026.
  • Syon Capital bought 3,844 Edwards Lifesciences shares in Q2 2026, an estimated $322K.
  • Edwards Lifesciences made up 0.05% of Syon Capital's portfolio in Q2 2026, its #324 holding.
  • Syon Capital first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 9 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.